Cargando…

Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer

Pancreatic cancer is one of the most aggressive and lethal types of cancer, and more effective therapeutic agents are urgently needed. Overexpressed cell surface antigens are ideal targets for therapy with monoclonal antibody (mAb)-based drugs, but none have been approved for the treatment of pancre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arias-Pinilla, Gustavo A., Dalgleish, Angus G., Mudan, Satvinder, Bagwan, Izhar, Walker, Anthony J., Modjtahedi, Helmout
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929441/ https://www.ncbi.nlm.nih.gov/pubmed/29731998 http://dx.doi.org/10.18632/oncotarget.25017

Ejemplares similares

Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer
por: Arias-Pinilla, Gustavo A., et al.
Publicado: (2020)

Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
por: Arias-Pinilla, Gustavo A., et al.
Publicado: (2021)

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer
por: Khan, Tanzeel, et al.
Publicado: (2020)

Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
por: Khelwatty, Said Abdullah, et al.
Publicado: (2019)

The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer
por: Khelwatty, Said, et al.
Publicado: (2016)

Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer
por: Puvanenthiran, Soozana, et al.
Publicado: (2018)

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells
por: Ioannou, Nikolaos, et al.
Publicado: (2013)

Unusual presentation of metastatic adenocarcinoma
por: Bagwan, Izhar N, et al.
Publicado: (2007)

Co-Expression of HER Family Members in Patients with Dukes’ C and D Colon Cancer and Their Impacts on Patient Prognosis and Survival
por: Khelwatty, Said Abdullah, et al.
Publicado: (2014)

HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer
por: Khelwatty, Said A., et al.
Publicado: (2021)

Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition
por: IOANNOU, NIKOLAOS, et al.
Publicado: (2016)

Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity
por: Dalgleish, Angus G., et al.
Publicado: (2018)

CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture
por: Haun, Randy S, et al.
Publicado: (2014)

Defining Genome-Wide Expression and Phenotypic Contextual Cues in Macrophages Generated by Granulocyte/Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Heat-Killed Mycobacteria
por: Bazzi, Samer, et al.
Publicado: (2017)

Cytokine/Chemokine Release Patterns and Transcriptomic Profiles of LPS/IFNγ-Activated Human Macrophages Differentiated with Heat-Killed Mycobacterium obuense, M-CSF, or GM-CSF
por: Bazzi, Samer, et al.
Publicado: (2021)

Detection of a Soluble Form of CD109 in Serum of CD109 Transgenic and Tumor Xenografted Mice
por: Sakakura, Hiroki, et al.
Publicado: (2014)

HOXB9 Overexpression Promotes Colorectal Cancer Progression and Is Associated with Worse Survival in Liver Resection Patients for Colorectal Liver Metastases
por: Martinou, Eirini, et al.
Publicado: (2022)

CD109 and squamous cell carcinoma
por: Qi, Ruixia, et al.
Publicado: (2018)

Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs
por: Puvanenthiran, Soozana, et al.
Publicado: (2016)

A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
por: Modjtahedi, Helmout, et al.
Publicado: (2014)

Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
por: Stanley, Aryan, et al.
Publicado: (2017)

Long-term Disease-free Survival Following Combination Multi-visceral and Metastatic Resection with Neoadjuvant FOLFIRINOX for Pancreatic Adenocarcinoma: A Case Report
por: Sodergren, Mikael, et al.
Publicado: (2015)

Spins and electromagnetic moments of $^{101–109}$Cd
por: Yordanov, D T, et al.
Publicado: (2018)

CD109 Plays a Role in Osteoclastogenesis
por: Wang, Yongqiang, et al.
Publicado: (2013)

Inhibitory Effects of Culinary Herbs and Spices on the Growth of HCA-7 Colorectal Cancer Cells and Their COX-2 Expression
por: Jaksevicius, Andrius, et al.
Publicado: (2017)

Evaluation of a novel monoclonal antibody mAb109 by immuno-PET/fluorescent imaging for noninvasive lung adenocarcinoma diagnosis
por: Zhu, Hua, et al.
Publicado: (2019)

Monoclonal antibodies targeting CD20
por: Chang, Chien-Hsing, et al.
Publicado: (2013)

Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?
por: Brunet, Laura Rosa, et al.
Publicado: (2015)

Suppression of skin tumorigenesis in CD109-deficient mice
por: Sunagawa, Masaki, et al.
Publicado: (2016)

Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers
por: Khelwatty, Said A, et al.
Publicado: (2015)

Descriptive analysis of incidental and operable gallbladder carcinoma cases: a UK centre experience
por: Karunaratne, Sanwandana, et al.
Publicado: (2022)

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
por: Modjtahedi, H., et al.
Publicado: (1993)

Extended Survival after Complete Pathological Response in Metastatic Pancreatic Ductal Adenocarcinoma Following Induction Chemotherapy, Chemoradiotherapy, and a Novel Immunotherapy Agent, IMM-101
por: Costa Neves, Mafalda, et al.
Publicado: (2015)

Response to: Monoclonal antibodies targeting CD20
por: Klein, Christian, et al.
Publicado: (2013)

CD109 expression is upregulated in penile squamous cell carcinoma
por: Dong, Fengyun, et al.
Publicado: (2017)

Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting
por: Yang, Hobin, et al.
Publicado: (2019)

Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
por: Ioannou, N, et al.
Publicado: (2011)

Safety of Redo Hepatectomy for Colorectal Liver Metastases after Selective Interarterial Radiation Therapy: A Case Report
por: Neofytou, Kyriakos, et al.
Publicado: (2014)

Monoclonal antibodies to CD44 and their influence on hyaluronan recognition
Publicado: (1995)

Novel CD20 monoclonal antibodies for lymphoma therapy
por: Cang, Shundong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sc20spis0odi6en1pnv99hbjpr